Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19

CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19

Authors

Berezhnyi Herman, Zelenska Kateryna, Kozhyna Наnna, Leshchyna Iryna, Lytvynenko Vasyl

Type of Article

Scientific Article

In the Section

diagnosis and treatment of mental and behavioral disorders.

Key words

COVІD-19, depression, cognitive state, psychoeducation, psychotherapy, anxiety, pharmacotherapy, quality of life

Index UDK:

616.89-085.851:616.98:578.834

DOI: https://doi.org/10.36927/2079-0325-V32-is4-2024-2

Abstract

In the course of the work, the clinical phenomenology was studied and a comprehensivesystem of therapy for mental disorders in people who have suffered from COVID-19 was developed.It was established that the clinical picture of mental disorders in the examined patientsis represented by depressive (29.1 % of patients), anxiety (33.4 %), asthenic-neurotic (24.2 %)and cognitive (13.3 %) syndrome complexes, and their phenomenology was described.Taking into account the data obtained during the comprehensive examination, a personalized system for correcting mental disorders in people who have suffered from COVID-19 wasdeveloped, which included the use of pharmacotherapy, psychotherapy and psychoeducation.Psychopharmacotherapy included the differentiated use of SSRI antidepressants and SSRInon-benzodiazepine anxiolytics, a short course of benzodiazepine.The psychotherapeutic program included the differentiated use of: cognitive behavioraltherapy, biosuggestive therapy, psychodynamic psychotherapy, art therapy, social skills training,desensitization, midfullness, relaxation exercises and cognitive training.Analysis of the clinical results of using the developed program of personalized therapyof mental disorders of people who have suffered COVID-19 has proven its effectiveness. Againstthe background of using the developed program, positive dynamics of the mental state, rapidreduction of anxiety-depressive and asthenic symptoms, improvement of cognitive functions,formation of adaptive types of attitude to the disease and improvement of the quality of lifeof people who have suffered COVID-19 were noted.

Pages

10-13

Year / Issue

2024, Volume 32, issue 4 (121)

Download PDF

Bibliography

1. Yong SJ. Long COVID or post-COVID-19 syndrome: putativepathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397.

2. Legido – Quigley H, Asgari N, Teo YY, Leung GM,Oshitani H, Fukuda K, et al. Are high-performing healthsystems resilient against the COVID-19 epidemic? Lancet. 2020 Mar 14;395(10227):848-850. doi: 10.1016/S0140-6736(20)30551-1.

3. Coronavirus: statisticsby country. URI: https://index.minfin.com.ua/ua/reference/coronavirus/geography/. (In Ukrainian).

4. Cheng WJ, Shih HM, Su KP, Hsueh PR. Risk factors for poorCOVID-19 outcomes in patients with psychiatric disorders.Brain Behav Immun. 2023 Nov;114:255-261. doi: 10.1016/j.bbi.2023.08.024.

5. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S,Arseneault L, et al. Multidisciplinary research prioritiesfor the COVID-19 pandemic: a call for action for mental healthscience. Lancet Psychiatry. 2020 Jun;7(6):547-560. doi: 10.1016/S2215-0366(20)30168-1.

6. Sheridan Rains L, Johnson S, Barnett P, Steare T, Needle JJ,Carr S, … Simpson A; COVID-19 Mental Health Policy ResearchUnit Group. Early impacts of the COVID-19 pandemic on mentalhealth care and on people with mental health conditions:framework synthesis of international experiences and responses.Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):13-24. doi:10.1007/s00127-020-01924-7.

7. Talevi D., Socci V., Carai M, Carnaghi G, Faleri S, Trebbi E, et al.Mental health outcomes of the COVID-19 pandemic. Riv Psichiatr.2020 May-Jun;55(3):137-144. doi: 10.1708/3382.33569.

Chaban O. S., Khaustova O. O. Mental healthduring the COVID-19 pandemic (features of psychologicalcrisis, anxiety, fear and anxiety disorders). NeuroNews. 2020;3(114):26—36. (In Ukrainian).

9. Mishchenko T. S., Mishchenko V. M. Neurological complicationsin patients with COVID-19. Psychiatry, neurology and medicalpsychology. 2021; 16:23—33. DOI: 10.26565/2312-5675-2021-16-03. (In Ukrainian).

10. Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM: An International Journal of Medicine. 2020Oct 1;113(10):707-712. doi: 10.1093/qjmed/hcaa202.

11. Maruta N. O., Fedchenko V. Yu., Panko T. V., Semikina O. Ye.,Lapinska O. R. Mental disorders in patients who have recoveredfrom the coronavirus disease Covid-19, psychological aspect. Ukrainian Bulletin of Psychoneurology. 2023; 31;2(115):54—62. DOI: https://doi.org/10.36927/2079-0325-V31-is2-2023-7. (In Ukrainian).

12. McLaughlin KA, Rosen ML, Kasparek SW, Rodman AM.Stress-related psychopathology during the COVID-19 pandemic. Behav Res Ther. 2022 Jul;154:104121. doi: 10.1016/j.brat.2022.104121.

13. Meaklim H, Saunders WJ, Byrne ML, Junge MF, Varma P,Finck WA, Jackson ML. Insomnia is a key risk factor for persistentanxiety and depressive symptoms: A 12-month longitudinalcohort study during the COVID-19 pandemic. J Affect Disord.2023 Feb 1;322:52-62. doi: 10.1016/j.jad.2022.11.021.

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII